Westfield Capital Management
SAGE

Westfield Capital Management’s Sage Therapeutics SAGE Stock Holding History

Westfield Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-353,603
Closed -$30.6M – 277
2020
Q4 		$30.6M Sell
353,603
-201,870
-36% -$14.9M 0.18% 156
2020
Q3 		$34M Sell
555,473
-6,984
-1% -$354K 0.22% 134
2020
Q2 		$23.4M Buy
562,457
+135,765
+32% +$4.93M 0.16% 158
2020
Q1 		$12.3M Buy
426,692
+179,483
+73% +$10.4M 0.11% 170
2019
Q4 		$17.8M Buy
247,209
+100,248
+68% +$12.3M 0.13% 172
2019
Q3 		$20.6M Buy
+146,961
New +$24.6M 0.17% 155

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return